# Phyton Biotech

通过植物细胞发酵生产紫杉醇，推进可持续紫杉烷生物制造，使API与红豆杉采伐脱钩。

Source: https://cn.bioecon.ru/companies/phyton-biotech/
Updated: 2026-07-09

- 国家: Germany

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 产能 | 在德国的紫杉醇原料年产能接近1,000公斤；产能可满足全球紫杉醇和多西他赛需求的1/3以上；全球设施总产能为200,000升 | https://phytonbiotech.com/apis/, https://phytonbiotech.com/apis/paclitaxel/, https://phytonbiotech.com/plant-cell-fermentation-technology/ |
| 认证 | 紫杉醇(paclitaxel)原料药适用性证书(CEP)；工厂通过cGMP认证 | https://phytonbiotech.com/phyton-biotech-nmpa-approval/, https://www.fiercepharma.com/manufacturing/phyton-biotech-receives-cep-for-paclitaxel-api-produced-by-plant-cell-fermentation |
| 监管批准 | 已通过FDA、EMA、EDQM、TGA、PMDA、加拿大卫生部（Health Canada）、KFDA及中国NMPA的检查和认证 | https://phytonbiotech.com/phyton-biotech-nmpa-approval/, https://phytonbiotech.com/plant-cell-fermentation-technology/, https://www.fiercepharma.com/manufacturing/phyton-biotech-receives-cep-for-paclitaxel-api-produced-by-plant-cell-fermentation |
| 生产基地 | 德国阿伦斯堡和加拿大温哥华 | https://phytonbiotech.com/plant-cell-fermentation-technology/, https://www.fiercepharma.com/manufacturing/phyton-biotech-receives-cep-for-paclitaxel-api-produced-by-plant-cell-fermentation, https://www.pharmacompass.com/pharma-services/api-manufacturing-services/phyton-biotech-llc |
| 员工人数 | 估计员工人数为68至139人 [中等置信度] | https://prospeo.io/c/phyton-biotech, https://www.datanyze.com/companies/phyton-biotech/113820575 |
| 营收 | 估计每年$1300万至$2150万 [中等置信度] | https://www.datanyze.com/companies/phyton-biotech/113820575 |

独立来源: datanyze.com, fiercepharma.com, pharmacompass.com, prospeo.io

## 技术

- [森林生物制药与植物化学物](https://cn.bioecon.ru/technology/forest-biopharma-phytochemicals/)